Conventional secondary genomic analysis relies on several disconnected tools, which is time-consuming and error-prone, driving up costs and delaying patient diagnosis. This newly developed AI-powered platform streamlines and automates the heavy lifting of genomic analysis. The aim of this project is to validate its accuracy by generating reports for 50 patients with non-ST-elevation acute coronary syndrome (NSTE-ACS), 30 patients with stable angina pectoris (SAP), and 50 controls. These reports will be compared with those produced by the conventional pipeline from the same sequencing data.